Figure 1

Concentrations of thrombospondin-1 (TSP-1) before and after radioiodine administration at consecutive time-points (visits 1–5), p=0.72 (Kruskal-Wallis’ ANOVA for repeated measures design).
Concentrations of thrombospondin-1 (TSP-1) before and after radioiodine administration at consecutive time-points (visits 1–5), p=0.72 (Kruskal-Wallis’ ANOVA for repeated measures design).